The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery (CAFE)

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Development of a new comprehensive method for perioperative prevention of atrial fibrillation paroxysms in cardiac surgery patients at the hospital stage. It is planned to recruit 70 patients who will undergo pericardial fenestration during the operation using the original technique during coronary artery bypass grafting (Patent No. 2647626 C1 Russian Federation), and will be prescribed colchicine (the drug Colchicum-dispert) in the perioperative period in order to prevent the development of paroxysms of atrial fibrillation in the postoperative period, and 70 cardiac surgery patients operated on using the standard technique (without performing the pericardial fenestration procedure intraoperatively), receiving non-steroidal anti-inflammatory drugs in the postoperative period.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Elective coronary artery bypass grafting on pump;

• signed informed consent to participate in the study.

Locations
Other Locations
Russian Federation
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
RECRUITING
Tomsk
Contact Information
Primary
Mariia L Diakova, PhD
prima.maria@mail.ru
+79039155049
Backup
Yuri Y Vechersky, PhD
vjj@cardio-tomsk.ru
+79039512225
Time Frame
Start Date: 2025-01-20
Estimated Completion Date: 2026-02-20
Participants
Target number of participants: 140
Treatments
Active_comparator: Control group
Standard technique without performing the pericardial fenestration procedure intraoperatively. Standard postoperative treatment
Experimental: Experimental group
Pericardial fenestration during coronary artery bypass grafting using the original technique.~Colchicine (Colchicum-dispert) administration 4 hours before surgery and for 10 days after surgery
Sponsors
Leads: Tomsk Cardiology Research Institute

This content was sourced from clinicaltrials.gov

Similar Clinical Trials